Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Renal function improves upon replacement of calcineurin inhibitors with mycophenolate mofetil

March 13, 2001

Heterocyclic compounds from Sankyo act as Th1-selective immunosuppressants

March 2, 2001

Treatment of T-cell-mediated diseases with new quinazoline derivatives

Feb. 26, 2001

Nabi StaphVAX elicits antibodies against resistant S. aureus strains

Feb. 26, 2001

Improved nucleoside immunomodulators in the ICN pipeline

Feb. 22, 2001

Chlamydia polypeptide and use in DNA vaccines

Feb. 21, 2001

BASB113 polynucleotides and polypeptides for use as vaccines

Feb. 21, 2001

New tuftsin analogues more potent than the parent compound and orally active

Feb. 20, 2001

Pyrimidine-based protein tyrosine kinase inhibitors and their use described by Merck

Feb. 16, 2001

Avax subsidiary to evaluate TK suicide gene therapy technology

Feb. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...